Latest filing published 23 Mar 2026 for NeuroPace Inc, €21k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Frank M. Fischer across 3 companies, led by Nevro Corp, NeuroPace Inc and Tenon Medical, Inc. The record holds 29 filings, for trades running from 25 May 2017 to 20 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 23 March 2026 came the latest disclosure, a share grant for €21k in NeuroPace Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations